Macrophages Drive Ferroptosis Resistance after Radiotherapy
Cancer Communications · 2026
DOI: 10.34133/cancomm.0039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Communications, 2026. Verfasst von Hyewon Chung und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Ferroptosis, Macrophages, Radiation Tolerance, Neoplasms. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Korea Research Institute of Ships and Ocean Engineering.
Abstract (Originalsprache)
Background
Radiotherapy eliminates most tumor cells but spares persister tumor cells that evade cell death and drive relapse. Increasing evidence suggests that stromal components of the tumor microenvironment influence treatment responses, yet whether macrophages actively reprogram tumor-intrinsic stress responses to promote radioresistance remains unclear. Here, we investigated the mechanisms by which macrophage–tumor cell interactions regulate ferroptosis and tumor survival after irradiation.
Methods
We used macrophage–tumor cell coculture systems, Transwell separation assays, and 3D microfluidic models to examine contact-dependent effects on tumor survival following irradiation. Kinome-wide small interfering RNA screening, RNA sequencing, lipidomic profiling, and quantitative proteomic analysis of secretomes were performed to identify signaling pathways and metabolic changes. Genetic and pharmacological perturbation of Ephrin receptor b4 (Ephb4) signaling were evaluated in vitro and in syngeneic mouse tumor models. Clinical relevance was assessed using transcriptomic analyses and immunohistochemical staining of patient tumor specimens.
Results
Macrophage contact reduced lipid peroxidation and cell death in irradiated tumor cells in a contact-dependent manner. Kinome screening identified Ephb4 as a key mediator induced by irradiation in tumor cells. Ephb4 engagement with ephrinb2 on macrophages initiated bidirectional signaling that increased expression of ferroptosis-protective genes (solute carrier family 7 member 11 [ Slc7a11 ], solute carrier family 3 member 2 [ Slc3a2 ], and glutathione peroxidase 4 [ Gpx4 ]) in tumor cells while activating the toll-like receptor 2- nuclear factor-kappa B pathway and interleukin-6 (IL-6) production in macrophages. Macrophage-derived IL-6 further sustained ferroptosis resistance in tumor cells, and Ephb4-driven secretion of cathepsin S amplified macrophage IL-6 production through a feedforward loop. Genetic or pharmacological inhibition of Ephb4 restored lipid peroxidation and markedly enhanced radiosensitivity in vitro and in vivo. Analysis of patient datasets demonstrated increased EPHB4 expression following radiotherapy and an association between high EPHB4 expression, reduced ferroptosis signatures, and poor treatment response.
Conclusions
These findings identify a macrophage-driven ferroptosis evasion program that enables tumor cell survival after irradiation and demonstrate that Ephb4 coordinates bidirectional tumor–macrophage signaling to sustain this resistance. Targeting the Ephb4–ephrinb2 axis represents a potential strategy to enhance ferroptosis and improve radiotherapy efficacy in resistant tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea.
- Institute of Endemic Diseases, Seoul National University Medical Research Center, Seoul, South Korea.
- College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, Gangwon, South Korea.
- Department of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, South Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.
- Cancer Research Institute, Seoul National University, Seoul, South Korea.
ORCID-Profile: Seung Hyeok Seok
Förderung
- National Research Foundation of Korea
- Korea Research Institute of Ships and Ocean Engineering
Zitieren
APA
Chung, H., Kim, S. W., Oh, J. W., Park, G. M., Cho, Y., Choi, H. S., Kim, M., Kim, K. P., Na, Y. R., Lee, H. S., Kim, H. J., & Seok, S. H. (2026). Macrophages Drive Ferroptosis Resistance after Radiotherapy. Cancer Communications. https://doi.org/10.34133/cancomm.0039
Vancouver
Chung H, Kim SW, Oh JW, Park GM, Cho Y, Choi HS, et al. Macrophages Drive Ferroptosis Resistance after Radiotherapy. Cancer Communications. 2026. doi:10.34133/cancomm.0039
BibTeX
@article{Chung2026,
author = {Chung, Hyewon and Kim, Sang Wha and Oh, Jae Won and Park, Gyu Mi and Cho, Yurim and Choi, Hae Suk and Kim, MinJi and Kim, Kwang Pyo and Na, Yi Rang and Lee, Hye Seung and Kim, Hak Jae and Seok, Seung Hyeok},
title = {Macrophages Drive Ferroptosis Resistance after Radiotherapy},
journal = {Cancer Communications},
year = {2026},
doi = {10.34133/cancomm.0039}
}
EUVIMED